CanSino Biologics, Inc. Class H's market cap is currently HK$13.15B. The company's EPS TTM is HK$-0.006538975020000001; its P/E ratio is ―; CanSino Biologics, Inc. Class H is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is HK
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
